Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQX-1125 tablet versus capsule bioequivalence study in healthy volunteers
NL-OMON42576Active, not recruiting
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of AQX-1125 in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Aquinox Pharmaceuticals. Primary endpoints: Adverse events, Clinical laboratory assessments and 13 more. Started Oct 2015; status: active, not recruiting.
02
Drugs
AQX-1125
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on NL-OMON42576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42576.